北美数字治疗市场预测至 2028 年 - COVID-19 影响和应用区域分析 [糖尿病、心血管疾病、中枢神经系统 (CNS) 疾病、呼吸系统疾病、戒烟、肌肉骨骼疾病等] 和分销渠道（患者、提供者、付款者和雇主）
No. of Pages: 127 | Report Code: TIPRE00028839 | Category: Technology, Media and Telecommunications
No. of Pages: 127 | Report Code: TIPRE00028839 | Category: Technology, Media and Telecommunications
市场的增长归因于慢性病和降低医疗成本的需求日益增长。然而，与数据安全相关的网络威胁和风险限制了市场的增长。
心脏病、中风、糖尿病和肥胖等慢性疾病占据了医疗保健的大部分任何国家的成本。根据世界卫生组织（WHO）的报告，2020年全球有4.63亿成年人患有糖尿病，预计到2045年这一数字将增至6.29亿。此外，根据美国疾病控制与预防中心（CDC）的数据）2018年公布的数据显示，美国每年有140万美国人被诊断患有糖尿病。根据国际糖尿病联盟发布的《2021 年 IDF 糖尿病地图集》，北美报告称 2021 年约有 5100 万人受到糖尿病影响，预计到 2045 年这一数字将达到 6300 万。根据美国心脏病学会的报告基金会表示，冠心病 (CHD) 是 2018 年美国的首要死因，其中心血管疾病 (CVD) 居其次，其次是中风 (16.8%)、高血压 (9.4%)、心力衰竭 (9.0%)、和其他CVD（17.9%）。到 2035 年，预计美国约有 1.3 亿成年人将患有某种形式的心血管疾病。
由于北美发达和发展中经济体的肥胖率正在迅速增加，久坐和不健康的生活方式。根据经济合作组织（OECD）2017年公布的数据，OECD地区约19.5%的成年人口患有肥胖症。韩国和日本这一比例不到6%，匈牙利、新西兰、墨西哥和美国则超过30%。预计到 2030 年，美国、墨西哥和英国的肥胖水平将分别达到约 47%、约 39% 和约 35%。
增强慢性疾病管理并为患者提供各种治疗选择，数字疗法有助于提供基于证据的治疗解决方案。它使患者能够更好地控制他们的护理，并为糖尿病等慢性病管理提供潜在的解决方案。因此，慢性病患病率的上升正在推动数字治疗市场的增长。
Strategic insights for North America Digital Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,740.46 Million |
| Market Size by 2028 | US$ 7,323.29 Million |
| Global CAGR (2021 - 2028) | 22.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 应用
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Digital Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Digital Therapeutics Market is valued at US$ 1,740.46 Million in 2021, it is projected to reach US$ 7,323.29 Million by 2028.
As per our report North America Digital Therapeutics Market, the market size is valued at US$ 1,740.46 Million in 2021, projecting it to reach US$ 7,323.29 Million by 2028. This translates to a CAGR of approximately 22.8% during the forecast period.
The North America Digital Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Digital Therapeutics Market report:
The North America Digital Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Digital Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Digital Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Digital Therapeutics Market
